论文部分内容阅读
目的:探究并分析两组方法治疗幽门螺旋杆菌感染阳性消化性溃疡复发率的前瞻性研究。方法:选取我院自2011年3月~2013年2月收治的幽门螺旋杆菌感染阳性患者64例,将其作为临床研究对象,随机分成治疗组、对照组每组均32例患者。治疗组患者采取奥美拉唑+阿莫西林+克拉霉素分散片进行治疗,对照组患者采取奥美拉唑+阿莫西林+呋喃唑酮进行治疗,观察两组患者治疗后疗效及不良反应情况。结果:治疗后治疗组与对照组Hp阴转患者分别为18例(56.25%)、13例(40.63%),P>0.05无统计学差异,此外出现各种症状患者均无明显差异(P>0.05)无统计学意义。结论:两组患者分别采取不同药物治疗后,疗效差异较小,不良反应小,对临床治疗有积极作用。
Objective: To explore and analyze the two groups of methods for the treatment of Helicobacter pylori infection-positive peptic ulcer recurrence rate of prospective study. Methods: Sixty-four patients with positive H. pylori infection in our hospital from March 2011 to February 2013 were selected and divided into treatment group and control group with 32 patients in each group. The patients in the treatment group were treated with omeprazole + amoxicillin + clarithromycin dispersible tablets, and the patients in the control group were treated with omeprazole + amoxicillin + furazolidone. The curative effect and adverse reactions of the two groups were observed. Results: After treatment, 18 cases (56.25%) and 13 cases (40.63%) were Hp negative conversion patients in the treatment group and the control group, respectively. There was no significant difference between the two groups (P> 0.05) 0.05) no statistical significance. Conclusion: The two groups of patients taking different drug treatment, the difference is small, adverse reactions, have a positive effect on clinical treatment.